|
FR2435905A1
(fr)
*
|
1978-09-13 |
1980-04-11 |
Anvar |
Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
|
|
US4315018A
(en)
*
|
1978-12-07 |
1982-02-09 |
Rossignol Jean F |
Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
|
|
DK147856C
(da)
*
|
1979-12-21 |
1985-06-10 |
Wellcome Found |
Analogifremgangsmaade til fremstilling af nitrothiazolinforbindelser
|
|
US5387598A
(en)
*
|
1994-04-13 |
1995-02-07 |
Rossignol; Jean-Francois |
Composition and galenic formulation suitable for combatting affections of the lower abdomen
|
|
US5578621A
(en)
*
|
1994-09-08 |
1996-11-26 |
Romark Lab Lc |
Benzamide derivatives
|
|
AP645A
(en)
*
|
1994-04-13 |
1998-04-24 |
Romark Laboratories Lc |
Benzamine derivative, compositions containing said derivative and use thereof.
|
|
US5859038A
(en)
*
|
1994-09-08 |
1999-01-12 |
Romark Laboratories, L.C. |
Method for treatment of helicobacter pylori infections
|
|
MX9604483A
(es)
*
|
1994-09-08 |
1998-02-28 |
Jean-Francois Rossignol |
Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
|
|
US5968961A
(en)
*
|
1997-05-07 |
1999-10-19 |
Romark Laboratories, L.C. |
Pharmaceutical compositions of tizoxanide and nitazoxanide
|
|
AU740022B2
(en)
*
|
1997-05-07 |
2001-10-25 |
Romark Laboratories, L.C. |
Pharmaceutical compositions of tizoxanide and nitazoxanide
|
|
AU756451B2
(en)
*
|
1997-05-07 |
2003-01-16 |
Romark Laboratories, L.C. |
Pharmaceutical compositions of tizoxanide and nitazoxanide
|
|
US5935591A
(en)
*
|
1998-01-15 |
1999-08-10 |
Romark Laboratories, L.C. |
Method for treatment of equine protozoal myeloencephalitis with thiazolides
|
|
US5925622A
(en)
*
|
1998-07-13 |
1999-07-20 |
Romark Laboratories, L.C. |
Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
|
GB0226930D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0325402D0
(en)
*
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
|
GB0327761D0
(en)
*
|
2003-11-29 |
2003-12-31 |
Astrazeneca Ab |
Compounds
|
|
GB0328178D0
(en)
*
|
2003-12-05 |
2004-01-07 |
Astrazeneca Ab |
Compounds
|
|
US20080312207A1
(en)
*
|
2004-02-18 |
2008-12-18 |
Craig Johnstone |
Compounds
|
|
RU2392275C2
(ru)
*
|
2004-02-18 |
2010-06-20 |
Астразенека Аб |
Бензамидные производные и их применение в качестве активирующих глюкокиназу агентов
|
|
TW200600086A
(en)
*
|
2004-06-05 |
2006-01-01 |
Astrazeneca Ab |
Chemical compound
|
|
UA90864C2
(en)
*
|
2004-09-09 |
2010-06-10 |
Ромарк Лебораториз, Л.К. |
Halogenated benzamide derivatives
|
|
US20060194853A1
(en)
*
|
2004-10-08 |
2006-08-31 |
Rossignol Jean F |
Alkyl benzamides
|
|
US7700640B2
(en)
|
2004-10-16 |
2010-04-20 |
Astrazeneca Ab |
Process for making phenoxy benzamide compounds
|
|
GB0423044D0
(en)
*
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
|
GB0423043D0
(en)
*
|
2004-10-16 |
2004-11-17 |
Astrazeneca Ab |
Compounds
|
|
CA2604640A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Romark Laboratories L.C. |
Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
|
|
US20110059941A1
(en)
*
|
2005-05-24 |
2011-03-10 |
Peter William Rodney Caulkett |
2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators
|
|
TW200714597A
(en)
*
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1910350A1
(en)
*
|
2005-07-09 |
2008-04-16 |
AstraZeneca AB |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
|
JP4651714B2
(ja)
*
|
2005-07-09 |
2011-03-16 |
アストラゼネカ アクチボラグ |
糖尿病の治療においてｇｌｋ活性化剤として使用するためのヘテロアリールベンズアミド誘導体
|
|
EP2027113A1
(en)
*
|
2005-07-09 |
2009-02-25 |
AstraZeneca AB |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
|
US9202182B2
(en)
*
|
2005-08-11 |
2015-12-01 |
International Business Machines Corporation |
Method and system for analyzing business architecture
|
|
TW200738621A
(en)
*
|
2005-11-28 |
2007-10-16 |
Astrazeneca Ab |
Chemical process
|
|
AU2007204963B2
(en)
*
|
2006-01-09 |
2012-09-27 |
Romark Laboratories, L.C. |
Viral hepatitis treatment
|
|
US7678791B2
(en)
*
|
2006-07-12 |
2010-03-16 |
Cumbre Ip Ventures, L.P. |
Nitroheteroaryl-containing rifamycin derivatives
|
|
CN100465169C
(zh)
*
|
2006-08-02 |
2009-03-04 |
杭州欣阳三友精细化工有限公司 |
硝唑尼特的制备方法
|
|
TW200825063A
(en)
*
|
2006-10-23 |
2008-06-16 |
Astrazeneca Ab |
Chemical compounds
|
|
CL2007003061A1
(es)
*
|
2006-10-26 |
2008-08-01 |
Astrazeneca Ab |
Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
|
|
JP2010513445A
(ja)
*
|
2006-12-21 |
2010-04-30 |
アストラゼネカ アクチボラグ |
Ｇｌｋアクチベーターとして有用な新規結晶性化合物
|
|
CN101007792B
(zh)
*
|
2007-01-31 |
2010-05-26 |
浙江大学 |
一种合成硝基噻唑苯酰胺化合物的方法
|
|
CN101835765B
(zh)
*
|
2007-08-03 |
2013-05-29 |
罗马克实验室有限公司 |
烷基磺酰基取代的噻唑化物类化合物
|
|
EP2324028A2
(en)
*
|
2008-08-04 |
2011-05-25 |
AstraZeneca AB |
Therapeutic agents 414
|
|
SG172060A1
(en)
|
2008-12-09 |
2011-07-28 |
Gilead Sciences Inc |
Modulators of toll-like receptors
|
|
LT2395840T
(lt)
|
2009-02-13 |
2020-07-10 |
Romark Laboratories, L.C. |
Nitazoksanido kontroliuojamo atpalaidavimo farmacinės kompozicijos
|
|
GB0902406D0
(en)
*
|
2009-02-13 |
2009-04-01 |
Astrazeneca Ab |
Crystalline polymorphic form
|
|
GB0902434D0
(en)
*
|
2009-02-13 |
2009-04-01 |
Astrazeneca Ab |
Chemical process
|
|
AR076221A1
(es)
*
|
2009-04-09 |
2011-05-26 |
Astrazeneca Ab |
Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
|
|
WO2010116177A1
(en)
|
2009-04-09 |
2010-10-14 |
Astrazeneca Ab |
A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
|
|
AP3074A
(en)
|
2009-05-12 |
2014-12-31 |
Romark Lab Lc |
Haloalkyl heteroaryl benzamide compounds
|
|
PT2445349T
(pt)
|
2009-06-26 |
2022-05-16 |
Romark Laboratories Lc |
Compostos e métodos para tratamento da gripe
|
|
CN101602744B
(zh)
*
|
2009-06-30 |
2011-06-01 |
青岛康地恩药业有限公司 |
一种硝唑尼特的制备方法
|
|
EP2808019B1
(en)
|
2012-01-27 |
2019-09-25 |
Siegfried Rhein S.A. De C.V. |
Improved nitazoxanide composition and preparation method thereof
|
|
MX340272B
(es)
|
2012-09-27 |
2016-06-30 |
Rhein Siegfried Sa De Cv |
Composicion sinergica de nitazoxanida y mebendazol, procesos para prepararla y el uso de dicha composicion para el tratamiento de la parasitosis humana.
|
|
EP3010345A4
(en)
*
|
2013-06-21 |
2017-04-12 |
The Regents of The University of California |
Expanded therapeutic potential in nitroheteroaryl antimicrobials
|
|
CN113577081A
(zh)
|
2014-07-11 |
2021-11-02 |
吉利德科学公司 |
用于治疗hiv的toll样受体调节剂
|
|
UY36298A
(es)
|
2014-09-16 |
2016-04-29 |
Gilead Science Inc |
Formas sólidas de un modulador del receptor tipo toll
|
|
US10100023B2
(en)
|
2014-11-11 |
2018-10-16 |
Romark Laboratories, L.C. |
Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
|
|
CN105175352A
(zh)
*
|
2015-10-27 |
2015-12-23 |
杭州澳医保灵药业有限公司 |
一种硝唑尼特的制备方法
|
|
CN106831640A
(zh)
*
|
2015-12-03 |
2017-06-13 |
江苏正大丰海制药有限公司 |
一种硝唑尼特晶体的制备方法
|
|
BR112018069974A2
(pt)
|
2016-03-31 |
2019-01-29 |
Romark Laboratories Lc |
compostos de tiazolida para o tratamento de infecções virais
|
|
MX384261B
(es)
|
2016-04-11 |
2025-03-14 |
Genfit |
Metodos de tratamiento para enfermedades colestasicas y fibroticas.
|
|
CA3046158A1
(en)
|
2017-01-27 |
2018-08-02 |
Genfit |
Pharmaceutical compositions for combination therapy
|
|
US11173149B2
(en)
|
2017-04-18 |
2021-11-16 |
Romark Laboratories L.C. |
Inhibition of protein disulfide-isomerase A3
|
|
WO2019241376A1
(en)
|
2018-06-14 |
2019-12-19 |
The Trustees Of Columbia University In The City Of New York |
Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof
|
|
BR112021020496A2
(pt)
|
2019-04-12 |
2021-12-07 |
Genfit |
Nitazoxanida e tiazolidas para uso no tratamento de doenças associadas ao estresse oxidativo
|
|
CN114630660A
(zh)
|
2019-10-28 |
2022-06-14 |
基恩菲特公司 |
具有抗氧化特性的联合疗法
|
|
US20230303504A1
(en)
|
2020-07-20 |
2023-09-28 |
Romark Laboratories, L.C. |
Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
|
|
JP2023538136A
(ja)
|
2020-08-24 |
2023-09-06 |
ロマーク ラボラトリーズ，リミティド カンパニー |
コロナウイルスに対するチアゾリドの利用
|
|
CN114044761B
(zh)
*
|
2021-02-24 |
2022-05-17 |
成都贝诺科成生物科技有限公司 |
一种新的硝基噻唑衍生物及其应用
|
|
WO2022218239A1
(zh)
*
|
2021-04-12 |
2022-10-20 |
杜心赟 |
新型噻唑类化合物及其制备方法和用途
|
|
WO2023058046A1
(en)
|
2021-10-05 |
2023-04-13 |
Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) |
An improved process for the preparation of nitazoxanide and intermediates thereof
|
|
CN116898846B
(zh)
*
|
2022-04-12 |
2025-10-24 |
成都贝诺科成生物科技有限公司 |
一种硝基噻唑衍生物在制备抑制幽门螺杆菌的抑菌剂中的用途
|